Cargando…

The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery

PURPOSE: The aims of this study were to evaluate long-term multidimensional fatigue in patients with brain metastases (BM) up to 21 months after Gamma Knife radiosurgery (GKRS) and (change in) fatigue as predictor of survival. METHODS: Patients with 1 to 10 BM, expected survival > 3 months, and K...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhaak, Eline, Schimmel, Wietske C. M., Sitskoorn, Margriet M., Hanssens, Patrick E. J., Butterbrod, Elke, Gehring, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423137/
https://www.ncbi.nlm.nih.gov/pubmed/37249646
http://dx.doi.org/10.1007/s00432-023-04857-1
_version_ 1785089379912384512
author Verhaak, Eline
Schimmel, Wietske C. M.
Sitskoorn, Margriet M.
Hanssens, Patrick E. J.
Butterbrod, Elke
Gehring, Karin
author_facet Verhaak, Eline
Schimmel, Wietske C. M.
Sitskoorn, Margriet M.
Hanssens, Patrick E. J.
Butterbrod, Elke
Gehring, Karin
author_sort Verhaak, Eline
collection PubMed
description PURPOSE: The aims of this study were to evaluate long-term multidimensional fatigue in patients with brain metastases (BM) up to 21 months after Gamma Knife radiosurgery (GKRS) and (change in) fatigue as predictor of survival. METHODS: Patients with 1 to 10 BM, expected survival > 3 months, and Karnofsky Performance Status ≥ 70, and Dutch non-cancer controls were included. Fatigue was measured with the Multidimensional Fatigue Inventory. Levels of fatigue between patients and controls were compared using independent-samples t-tests. Linear mixed models were used to evaluate fatigue within the patient group up to 21 months after GKRS. Pre-GKRS fatigue and minimal clinically important (MCI) changes in fatigue in the first three months (defined as a 2-point difference) after GKRS were evaluated as predictors of survival time. RESULTS: Prior to GKRS, patients with BM (n = 92) experienced significantly higher fatigue on all subscales than controls (n = 104). Over 21 months, physical fatigue increased, and mental fatigue decreased significantly. More specifically, general, and physical fatigue increased significantly between pre-GKRS and 3 months, followed by stable scores between 3 (n = 67) and 6 (n = 53), 6 and 12 (n = 34) and 12 and 21 (n = 21) months. An MCI increase in general or physical fatigue over the first 3 months after GKRS was a significant predictor of shorter survival time. CONCLUSION: Except for mental fatigue, all aspects of fatigue remained elevated or further increased up to 21 months after treatment. Furthermore, an increase in general or physical fatigue within three months after GKRS may be a prognostic indicator for poorer survival. CLINICALTRIALS.GOV IDENTIFIER: NCT02953756, November 3, 2016. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04857-1.
format Online
Article
Text
id pubmed-10423137
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104231372023-08-14 The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery Verhaak, Eline Schimmel, Wietske C. M. Sitskoorn, Margriet M. Hanssens, Patrick E. J. Butterbrod, Elke Gehring, Karin J Cancer Res Clin Oncol Research PURPOSE: The aims of this study were to evaluate long-term multidimensional fatigue in patients with brain metastases (BM) up to 21 months after Gamma Knife radiosurgery (GKRS) and (change in) fatigue as predictor of survival. METHODS: Patients with 1 to 10 BM, expected survival > 3 months, and Karnofsky Performance Status ≥ 70, and Dutch non-cancer controls were included. Fatigue was measured with the Multidimensional Fatigue Inventory. Levels of fatigue between patients and controls were compared using independent-samples t-tests. Linear mixed models were used to evaluate fatigue within the patient group up to 21 months after GKRS. Pre-GKRS fatigue and minimal clinically important (MCI) changes in fatigue in the first three months (defined as a 2-point difference) after GKRS were evaluated as predictors of survival time. RESULTS: Prior to GKRS, patients with BM (n = 92) experienced significantly higher fatigue on all subscales than controls (n = 104). Over 21 months, physical fatigue increased, and mental fatigue decreased significantly. More specifically, general, and physical fatigue increased significantly between pre-GKRS and 3 months, followed by stable scores between 3 (n = 67) and 6 (n = 53), 6 and 12 (n = 34) and 12 and 21 (n = 21) months. An MCI increase in general or physical fatigue over the first 3 months after GKRS was a significant predictor of shorter survival time. CONCLUSION: Except for mental fatigue, all aspects of fatigue remained elevated or further increased up to 21 months after treatment. Furthermore, an increase in general or physical fatigue within three months after GKRS may be a prognostic indicator for poorer survival. CLINICALTRIALS.GOV IDENTIFIER: NCT02953756, November 3, 2016. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04857-1. Springer Berlin Heidelberg 2023-05-30 2023 /pmc/articles/PMC10423137/ /pubmed/37249646 http://dx.doi.org/10.1007/s00432-023-04857-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Verhaak, Eline
Schimmel, Wietske C. M.
Sitskoorn, Margriet M.
Hanssens, Patrick E. J.
Butterbrod, Elke
Gehring, Karin
The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery
title The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery
title_full The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery
title_fullStr The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery
title_full_unstemmed The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery
title_short The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery
title_sort long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after gamma knife radiosurgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423137/
https://www.ncbi.nlm.nih.gov/pubmed/37249646
http://dx.doi.org/10.1007/s00432-023-04857-1
work_keys_str_mv AT verhaakeline thelongtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT schimmelwietskecm thelongtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT sitskoornmargrietm thelongtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT hanssenspatrickej thelongtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT butterbrodelke thelongtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT gehringkarin thelongtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT verhaakeline longtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT schimmelwietskecm longtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT sitskoornmargrietm longtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT hanssenspatrickej longtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT butterbrodelke longtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery
AT gehringkarin longtermcourseandrelationshipwithsurvivalofmultidimensionalfatigueinpatientswithbrainmetastasesaftergammakniferadiosurgery